DaBlaCa-16: Retrosigmoid Versus Conventional Ileal Conduit in Robot-assisted Radical Cystectomy, the MOSAIC Randomized Controlled Trial—Feasibility and 90-day Postoperative Complications

Simone Buchardt Brandt*, Stefanie Korsgaard Körner, Rikke Vilsbøll Milling, Ninna Kjær Nielsen, Pernille Skjold Kingo, Ulla Nordström Joensen, Lasse Bro, Thor Knak Jensen, Astrid Helene Livbjerg, Knud Fabrin, Marie Louise Vrang, Michael Vangedal, Gitte Wrist Lam, Jørgen Bjerggaard Jensen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

2 Citations (Scopus)
14 Downloads (Pure)

Abstract

Background
Approximately 15% of patients undergoing radical cystectomy (RC) develop benign ureteroenteric strictures. Of these strictures, the majority are located in the left ureter. To lower the rate of strictures, a retrosigmoid ileal conduit has been suggested.

Objective
To investigate the feasibility and safety of a retrosigmoid ileal conduit during robot-assisted RC in bladder cancer patients.
Design, setting, and participants
This randomized controlled trial included 303 patients from all five cystectomy centers in Denmark from May 2020 to August 2022. Participants were diagnosed with bladder cancer and scheduled for robot-assisted RC with an ileal conduit.

Intervention
Intervention group: a retrosigmoid ileal conduit was constructed using approximately 25 cm of the terminal ileum and tunneled behind the sigmoid where the left ureter was anastomosed from end to side. Control group: the conventional ileal conduit ad modum Bricker with individual end-to-side anastomoses.

Outcome measurements and statistical analysis
Patients were analyzed by the intention-to-treat approach. Complications within 90 d were categorized using the Clavien-Dindo grading system and compared using Fisher’s exact test. Wilcoxon’s test was used for pre- and postoperative renal function.

Results and limitations
Of the 149 patients randomized for the retrosigmoid ileal conduit (MOSAIC), a total of 137 (92%) patients received the allocated conduit. Postoperative complications were distributed equally between the two groups. The relative risk of Clavien-Dindo complications of grade ≥III was 1.12 (95% confidence interval: 0.96–1.31) in the intervention group compared with the control group.

Conclusions
The retrosigmoid ileal conduit with robot-assisted RC was technically feasible. Early postoperative complications were not significantly different when comparing the two groups. Further investigation of long-term complications, including strictures, is needed.

Patient summary
We compared a conventional urinary diversion with a longer conduit to prevent constriction from developing in the ureters. The new conduit is feasible and safe within the first 90 d, with no differences in postoperative complications from those of the conventional diversion.
Original languageEnglish
JournalEuropean Urology Open Science
Volume60
Pages (from-to)8-14
Number of pages7
ISSN2666-1683
DOIs
Publication statusPublished - Feb 2024

Bibliographical note

© 2023 The Author(s).

Keywords

  • Benign ureteroenteric strictures
  • Muscle-invasive bladder cancer
  • Ninety-day complications
  • Radical cystectomy
  • Retrosigmoid ileal conduit
  • Robot-assisted surgery

Fingerprint

Dive into the research topics of 'DaBlaCa-16: Retrosigmoid Versus Conventional Ileal Conduit in Robot-assisted Radical Cystectomy, the MOSAIC Randomized Controlled Trial—Feasibility and 90-day Postoperative Complications'. Together they form a unique fingerprint.

Cite this